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HIV-1 Tat is a viral protein produced by HIV that causes structural changes to neurons 
and inflammation. Tat is implicated in deficits in the functions of several brain areas including 
hippocampal-dependent memory. Contextual fear condition (CFC) can be used to observe 
memory by associating a fear-inducing stimulus with a certain place. Studies show that lesioning 
the hippocampus reduces contextual fear related behaviors, supporting the use of CFC as a 
measure of hippocampal function. In the current study, three experiments were run to determine 
the most effective conditioning procedure for the Tat transgenic mouse, a neuroHIV model. A 
2x2, 0.4 mA arrangement was found to produce the least variability between subjects. However, 
the multiple-trial conditioning in this procedure may provide extensive learning, essentially 
rescuing neurologically compromised subjects. This further raises concerns about the validity of 
comparisons between the effectiveness of contextual versus cued fear conditioning. Future 
studies should assess hippocampal neurodegeneration associated with predicted behavioral 
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CHAPTER 1: INTRODUCTION 
 
 Human Immunodeficiency Virus (HIV) is a disease that targets the immune system and, 
without treatment, can result in the development of acquired immune deficiency syndrome 
(AIDS). Research in the treatment of HIV has rapidly advanced over the past several decades, 
but there are still approximately 37.9 million people around the world living with HIV (World 
Health Organization, 2019). Since its discovery in the 1990’s, combination antiretroviral therapy 
(cART) has been used to treat nearly 23.3 million people (World Health Organization, 2019). 
cART reduces HIV-1 replication, increases chance of survival, and improves the overall life 
quality of those infected (Cohen et al., 2011). However, cART is limited in its ability to affect 
the central nervous system (CNS) and therefore is unable to protect against neurological 
disorders and impairments caused by HIV (Ellis et al., 2017; Heaton et al., 2010). Even after 
cART treatment, those infected with HIV can develop HIV-associated neurocognitive disorder 
(HAND), which can lead to neurodegenerative-associated impairments in motor skills, language, 
abstraction-executive, working memory, attention, and inhibitory control (Clifford & Ances, 
2013). In the post-cART era, we see specific effects on memory tasks involving the hippocampus 
and the prefrontal cortex (PFC) (Heaton et al., 2010, 2011; McArthur et al., 2010). 
 Transactivator of transcription (Tat) is a viral protein released by HIV-infected cells. Tat 
has been found in the brains of patients with HIV (Hudson et al., 2000) and is believed to be a 
major contributor to the neurodegenerative damage observed in HAND (Fitting et al., 2014; 









cART, and is still present in the cerebrospinal fluid (CSF) of HIV+ individuals after treatment 
(Henderson et al., 2019). The viral protein activates glutamatergic NMDA receptors (NMDAR), 
causing excitotoxic influx of calcium and sodium, as well as mitochondrial instability (Fitting et 
al., 2014; Haughey et al., 2001). The activation of AMPA receptors (AMPARs) by neurotoxic 
glutamate release upregulates NMDA-mediated toxicity (Longordo et al., 2006), leading to 
dendritic degeneration and inflammation (Mattson et al., 2005; Green et al., 2018). Extended 
NMDA exposure results in elevated sodium levels, ionic imbalances and loss of calcium 
homeostasis in dendrites (Vander Jagt et al., 2008). This synaptodendritic injury manifests as 
swellings and structural defects caused by excessive levels of sodium and calcium (Greenwood 
et al., 2007). Under Tat conditions, microtubule associated protein 2 antibody (MAP2ab) is 
downregulated, signifying loss of dendritic structure, and glial fibrillary action protein (GFAP) 
and ionized calcium-binding adaptor molecule 1 (IBA-1) are upregulated, signifying increase in 
neuroinflammatory responses. Tat has been shown to cause neuronal injury and 
neuroinflammation in various brain regions, dependent on the length of expression induced 
(King et al., 2006). Specifically, studies have shown neurotoxic damage in the striatum of 
HIV/Tat transgenic rodent models (Bruce-Keller et al., 2008; Bansal et al., 2000; Hayman et al., 
1993), including dendritic varicosities and fragmentation (Fitting et al., 2010, 2014). Exposure to 
Tat also result in reduced spine density and synapse loss in the hippocampus of Tat transgenic 
models (Fitting et al., 2013; Kim et al., 2008). These injuries are known to highly correlate with 
neurocognitive deficits that can be observed in behavioral studies. Hippocampal neurocognitive 
deficits in animal models can be assessed through tasks, such as the Morris Water Maze and 









distance and latency for animals to reach the platform. Another method, fear conditioning, can be 
used to study hippocampal deficits related to context or cued stimuli. Spatial learning and 
memory deficits related to hippocampal damage and impaired consolidation of contextual 
memory can be quantified using contextual fear conditioning (CFC) experiments (Fitting et al., 
2013). Lesioning studies have shown that contextual memory, studied through CFC, is 
dependent on hippocampal function (Goosens et al., 2001; Phillips et al., 1992). 
 In the present study we are specifically interested in the effects that Tat has on the 
hippocampus and its related behavior. HIV-1 Tat’s effects on the hippocampus and memory can 
be studied through CFC, a form of Pavlovian conditioning. CFC can be used to observe 
contextual memory because it causes healthy subjects to associate a specific context with a fear-
inducing stimulus. In Pavlovian conditioning, subjects learn to associate a conditioned stimulus 
(CS) with an unconditioned stimulus (US). This learning involves presenting a CS with an US 
that results in an unconditioned response (UR). After sufficient pairings, the CS should elicit a 
conditioned response (CR) without the presence of the US. In contextual fear conditioning, mice 
are measured for fear-indicative freezing behavior after being conditioned to an electrical foot 
shock. This can be done by pairing a CS, the context, with a US of a foot shock. The foot shock 
(US) elicits freezing behavior (UR), a fear-response in mice. After successful pairing, the context 
as the CS should produce freezing (CR), regardless of whether or not the foot shock (US) is 
present. Ultimately, the subject should learn to associate the context it is in to the electric shock, 
and thus exhibit a fear response of freezing when placed in the context. 
 As shown by lesioning studies, contextual memory is dependent on hippocampal function 









injury in the hippocampus, CFC can be used to assess the extent of Tat’s effect on contextual 
memory and potential associated deficits. In this study, we will be testing whether the expression 
of doxycycline-induced HIV-1 Tat for 3 months decreases fear-conditioned responses using a 
Tat transgenic mouse model. To measure hippocampal deficits, we will be fear-conditioning 
Tat(+) and Tat(-) transgenic mice in one context and reintroducing them to the same context 24 
hours later, measuring for fear-indicative freezing behavior in order to test for the subject’s 
ability to recall the fearful context. The purpose of these studies is to formalize a fear 
conditioning protocol in Tat transgenic mice in order to decrease variability, and study whether 




























 The experiment used 80-day old doxycycline (DOX)-inducible, brain-specific HIV-1IIIB 
Tat1-86 transgenic mice developed on a C57BL/6J hybrid background (Bruce-Keller et al., 2008; 
Hahn et al., 2015). Subjects were bred and kept in Davie Hall Animal Facility. The mice were 
single housed when DOX food was administered and provided water and food ad libidum. 
Animals were kept at a 12h light/dark cycle and were tested on during the night cycle. All 
experimental procedures were approved by the University of North Carolina at Chapel Hill 
Institutional Animal Care and Use Committee (IACUC). 
 As summarized in Bruce-Keller et al. (2008) Tat expression, under the control of a 
tetracycline-responsive promoter controlled by glial fibrillary acidic protein (GFAP) expression, 
is induced with chow containing 6 mg/g DOX (product TD.09282; Harlan, Indianapolis, IN). 
Inducible Tat(+) transgenic mice express both GFAP-rtTA and TRE-tat genes, while control 
Tat(-) transgenic mice express only the GFAP-rtTA genes. All transgenic mice were genotyped 
to confirm presence of Tat and/or rtTA transgenes. Both control Tat(-) and experimental Tat(+) 
received DOX for three months to induce Tat expression. 
2.2 Apparatus 
 
 Testing was done in a dark room with red fluorescent lighting and an air-conditioner 
running as background noise. All experimental chambers (MED Associates ENV-307W) were 









also contained a shock scrambler (ENV-4145: 115 V AC, 60 Hz) on the grid floor. A 28 V DC, 
100 mA white house light (MED Associates ENV-215W) was mounted on the wall to illuminate 
the chamber during testing. Each chamber contained a video camera (Amcrest 1080P Quadbrid) 
to record each experimental session and a DVR (101AV 16CH 1080p) was used to collect the 
recorded videos.  
2.3 Behavioral Procedure 
 
  Mice were habituated to the experimenter by being handled for 2-3 minutes daily, one 
week before the initial acquisition phase. Weights were recorded weekly for two months prior to 
acquisition to ensure subjects were eating DOX and maintaining a healthy body weight. Both 
groups [Tat(+) and Tat(-)] were exposed to the same experimental conditions. During the fear 
conditioning phase, subjects were placed in the chamber and administered the shock pattern 
respective to the experiment.  Unless otherwise stated, shocks occurred at 5 and 8 minutes. 
 Testing occurred in the same context 24 hours after the initial fear conditioning. After a 
10 second period from initial placement of subjects in the chambers, freezing behavior was 
measured from the recorded videos. The percentage freezing time was taken from the number of 
5 second interval periods within the first five minutes of the trial in which the subject exhibited 
freezing behavior. Only the first five minutes were used to code freezing because it is known to 
be the period of time of most animal freezing, as afterwards animals are more subject to within 
session extinction. Freezing was defined as the subject ceasing all movement for more than one 
second. Coding utilized the bin method, where a whole 5-second bin was marked as “freezing” if 









videos were coded by one person, and an additional person conducted reliability checks on 31% 
of the videos to ensure consistent agreement above 80%.  
2.4 Statistical Analysis 
 
We measured the percentage of freezing of the testing trial. The independent variables 
were sex (female, male) and genotype [Tat(+), Tat(-)], and the dependent variable was the 
percentage freezing time in the testing trial. All descriptive statistics were reported as means (M) 
± standard error of the mean (SEM). The analyses conducted used an alpha value of p < 0.05 as a 
measure of statistical significance. To study test differences between Tat(+)/(-), an independent 
samples t-test was run. A two-way analysis of variances (ANOVA) with Sex (male, female) and 
Genotype [Tat(-), Tat(+)] as factors was conducted for experiment 3. For all studies, we 
predicted that the Tat(+) mice will exhibit less freezing behavior compared to the Tat(-) mice in 
the testing trial, due to a deficit in contextual memory as a result of hippocampal damage. 
Population effect size was represented using w2 as an unbiased estimate (Yiğit and Mendes, 



















CHAPTER 3: EXPERIMENT 1 
 
 Experiment 1 was used as a pilot study to determine whether freezing behavior could be 
produced from administration of an electrical shock in our model. In their CFC paradigm, Fitting 
et al. (2013) used a 2 s, 0.7 mA shock after three minutes in an experimental chamber and re-
introduced subjects to the same context, measuring freezing 24 h after conditioning. This study 
found that Tat(+) mice froze significantly less than Tat(-) mice when re-exposed to the context, 
suggesting that Tat expression impairs contextual memory consolidation and/or retrieval. Hahn 
et al.’s (2016) cued fear conditioning paradigm consisted of 3 tones of 20 s, each co-terminated 
with a 2 s, 0.7 mA shock. During the extinction phase, subjects were measured for freezing 
behavior 24 h after conditioning in a new context, paired with the original tone for 200 s. This 
study found that there were no significant differences between Tat(+) and Tat(-) mice 
immediately before and after the shock on the initial conditioning day. Additionally, the study 
found that Tat(+) mice show delayed extinction of freezing behavior in different contexts, with 
no significant difference between Tat(+) and Tat(-) after day 3, possibly a result of elevated 
anxiety behavior in Tat(+) mice, rather than differences in memory consolidation of cued fear. 
These studies were used to develop the methods utilized in these experiments, as a way to unify 
both studies’ methodology (1 shock vs.  3 shocks) under a single procedure (2 shocks) and 
investigate the apparent discrepancy in contextual and cued fear conditioning. Based on these 









hypothesized that Tat(+) mice would freeze significantly less than Tat(-) mice due to failure to 
consolidate fear into long-term memory.  
3.1 Materials and Methods 
 
 3.12 Subjects. The study utilized a sample of 16 male Tat transgenic mice as described 
above [n = 8 Tat(+)]. 
 3.13 Apparatus. We used the same apparatus as described above. 
3.14 Procedure. Due to a programming error, subjects were placed in the chamber for 10 
min without a shock, thus introducing a habituation phase into the experiment. After 24 h, the 
fear conditioning phase occurred in the same context of the chamber. Two unsignaled 0.4 mA 
shock presentations were administered as described above. Testing and coding were conducted 
as specified in the general procedure. 
3.2 Results and Discussion 
 
 An independent samples t-test found that there was no significant difference t(14) = -
.256, p = .801, between the freezing percentages of Tat(+) (M = 0.14, SEM = 0.03) and Tat(-) (M 
= 0.15, SEM = 0.32) mice (Figure 1). This indicates that Tat(+) and Tat(-) mice displayed a 
similar amount of freezing behavior, suggesting that genotype did not affect consolidation and 
retrieval of the fearful memory.  
 The study showed no significant differences between the two groups of Tat(+) and Tat(-) 
transgenic mice. This may have been partially due to the error in programming that resulted in an 
accidental habituation phase. The former safe encounter with the context may have interfered 
with the latter fear conditioning, resulting in subjects having less of a fear response to the 









of 0.4 mA and later exposure to the shock at 5 min in this study than the higher intensity shock 
of 0.7 mA and earlier exposure to the shock at 3 min in other studies (Fitting et al., 2013; Hahn 
et al., 2016). The 0.4 mA shock was used in this experiment because previous studies have 
shown a 0.4-0.6 mA shock level to produce optimal learning of context in the C57BL/6 mouse 
(Curzon et al., 2009). An intermediate intensity shock also provides the potential for extinction 
in future studies. The administration of the shock at 5 and 8 min was done with the goal of 
eliciting more freezing during the first five minutes of testing, as the timing of the conditioned 
shock neared; however, it may have contributed to an extended habituation phase and slowed 
conditioned learning. The use of two shocks, rather than three (Hahn et al., 2016), may have also 
contributed to the lack of significant results. The two-shock paradigm was used as an 
intermediate between Fitting (2013) and Hahn (2016) methodology but may have been 
insufficient when paired with the lower intensity shock. Learning generally increases with the 
amount of spaced training (Lauterborn et al., 2019) and an additional shock may cause subjects 
to more closely associate the context with the shocking experience, especially within different 
strains of mice (Chaudhury et al., 2002). Shock titration experiments are commonly used to 
ensure an appropriately working apparatus. These experiments entail using different shock 
intensities and shock recurrences in order to determine the most effective conditioning method 
for subjects. The lack of replication could be potentially attributed to the fact that the study 














CHAPTER 4: EXPERIMENT 2 
 
 The results of experiment 1 showed that the procedure utilized failed to produce 
consistent results, as subject percentages had a high variability within groups, and overall 
freezing was low. In order to determine a more-effective electrical shock method, experiment 2 
was used as a shock titration experiment. Four configurations were used: two 0.6 mA shock in 
one day [2x1 (.6)], two 0.8 mA shocks in one day [2x1 (.8)], four 0.4 mA shocks in one day 
(4x1), and two 0.4 mA for two days (2x2). Additionally, this study removed the habituation 
phase at 24 h before fear conditioning, as the initial safe exposure to the context may have 
decreased the effectiveness of the fear conditioning in experiment 1. We hypothesized that the 
two 0.4 mA shocks over two days would produce the most reliable freezing percentages, closest 
to a value of 50% freezing, because of the repeated conditioning to the context. The freezing 
percentage was selected to be an intermediate value, so that extinction in future studies may be 
possible. As in the previous study, we also hypothesized that Tat(+) transgenic mice would 
freeze less than Tat(-) transgenic mice. 
4.1 Materials and Methods 
4.12 Subjects. The study utilized a sample of 32 Tat transgenic mice as described above 
[n = 16 Tat(+), n = 16 female].  









4.14 Procedure. Subjects were not DOX-ed prior to the study and therefore were 
effectively of the same genotype [Tat(-)]. Subjects were placed in the apparatus during the fear 
conditioning phase. Subjects were divided into four groups. The 4x1 arrangement consisted of an 
unsignaled 0.4 mA shock presentation administered for 2 s at 5, 8, 11, and 14 min. The 2x2 
arrangement consisted of an unsignaled 0.4 mA shock presentation administered for two seconds 
first after five minutes, and again three minutes following the first shock in the chamber for two 
consecutive days. The 2x1 (.6) and 2x1 (.8) arrangements consisted of an unsignaled 0.6 and 0.8 
mA shock presentation, respectively, administered for two seconds first after five minutes, and 
again three minutes following the first shock in the chamber. Testing and coding were conducted 
as specified in the general procedure. 
4.2 Results and Discussion 
The 4x1 arrangement (M = 0.48, SEM = 0.12) had the least average freezing. The 2x2 
arrangement (M = 0.54, SEM = 0.06) was found to have the least variability and average closest 
to 0.5. The 2x1 (.6) arrangement (M = 0.62, SEM = 0.07) and 2x1 (.8) arrangement (M = 0.70, 
SEM = 0.06) had the highest average freezing (Figure 2). 
One study, Curzon et al. (2009), utilized a shock titration experiment, administering 
either no shock, a 0.17 mA shock, or 0.35 mA shock to mice. The study found that both groups 
subject to a foot shock froze significantly more than the group without a shock, with the 0.35 mA 
group freezing the most on average. Similarly, our study found the highest intensity shocks (2x1 
0.6 mA, 2x1 0.8 mA arrangement) to produce the highest average of freezing. However, having a 
high ceiling of freezing may impede results, as differences between groups may be harder to 









shocks, as fear is strongly associated with the context. Another study (Chwang et al., 2006) used 
a 3x1 0.5 mA arrangement, similar to our 4x1 0.4 mA arrangement, and found that the group 
treated with DMSO froze significantly more than both the group treated SL327 and the control 
group. The study indicates that the 3x1 (.5) arrangement was successful in producing differences 
between different groups. Interestingly, in our study the 4x1 (.4) arrangement had the least 
average freezing and the most variability, perhaps due to the lower intensity of the shock and 
lack of multiple trials over multiple days to more strongly consolidate the memory (Kant et al., 
2019). The 2x2 arrangement was determined to be the most reliable based on its average being 
closest to 0.5 (a measure of freezing that could potentially be extinguished) and its variability 
being the lowest. Experiment 3 utilized the 2x2 arrangement in order to model a more effective 






















CHAPTER 5: EXPERIMENT 3 
 Experiment 3 was a repeat of experiment 1 using the most effective method, the 2x2 
arrangement. Additionally, the study introduced female subjects, as to extend the applicability of 
the study and analyze whether freezing effects would differ across sexes. Experiment 3 tested the 
hypothesis that female and male Tat(+) mice would freeze significantly less than female and 
male Tat(-) mice.  
5.1 Method 
 5.2 Subjects. The study utilized 32 Tat transgenic mice as described above [n = 16 
Tat(+), n = 16 female]. 
 5.3 Apparatus. We used the same apparatus as described above. 
 5.4 Procedure. The procedure was as described above in the 2x2 arrangement in 
experiment 2. Testing and coding were conducted as specified in the general procedure. 
5.2 Results and Discussion 
 A two-way ANOVA, with sex (2 levels: female, male) and genotype [2 levels: Tat(-), 
Tat(+)] as factors, found that there was no significant interaction between sex and genotype on 
freezing, F(1, 30) = 1.14, p  = .295, ω2 = .04. Female Tat(+) mice (M = 0.43, SEM = 0.10) froze 
the least on average, but the difference was not significant. Male Tat(-) mice (M = 0.51, SEM = 
0.12) followed in percentage freezing. Female Tat(-) (M = 0.55, SEM = 0.09) and male Tat(+) (M 









female Tat(-) and male Tat(+) mice froze the most, but there was no significant difference or 
interaction between Tat(+) and Tat(-) subjects and male and female subjects. 
 After minimizing variability in the CFC procedure, the study still did not find significant 
genotype or sex differences. This differs from the findings of Fitting et al. (2013), which showed 
that Tat(+) transgenic mice froze significantly less than Tat(-) mice 24 h after fear-conditioning. 
Furthermore, there was no significant difference between Tat(+) and Tat(-) mice freezing before 
or immediately after the foot shock, indicating the results were caused by differences in memory 
consolidation and retrieval, not pain sensitivity or motor control. Conversely, Hahn et al. (2016) 
found that Tat(+) mice showed delayed extinction of cued freezing in a different context 
compared to Tat(-) mice, which could suggest that Tat(+) mice were able to consolidate and 
retrieve the cued fear memory. Freezing between groups was equivalent after three days of 
extinction, resulting in the delayed extinction to be interpreted as elevated anxiety in Tat(+) mice 
(Schneider et al., 2015; Sotres-Bayon et al., 2004). This suggests that CFC deficits may be subtle 
and thus disappear after repeated training. Although a 2x2 arrangement was shown to decrease 
variability in experiment 2, the repeated training may have diminished the differences between 

















CHAPTER 6: DISCUSSION 
 The purpose of these studies was to find the most effective CFC procedure for Tat 
transgenic mice, with the goal of using the established arrangement for future research in 
contextual memory of HAND models. Experiment 1 found no significant differences between 
Tat(+) and Tat(-) transgenic mice, although freezing behavior was produced. In the following 
experiment 2, a shock titration study determined that a 2x2 arrangement of 2 s, 0.4 mA foot 
shocks produced the least variability in subject freezing out of the other three arrangements [4x1, 
2x1 (.6), 2x1 (.8)]. Experiment 3 used these results to replicate the 2x2 arrangement with a larger 
sample size and the addition of female subjects. There were no significant differences in freezing 
percentages or interactions between genotype and sex found. 
 There were no significant differences in freezing found between groups, even after the 
2x2 arrangement was identified as the method with least variability. This differs from Fitting et 
al. (2013), which used a single 2 s, 0.7 mA foot shock, and found that Tat(+) froze significantly 
less when reintroduced to the context 24 h later. Hahn et al. (2016), instead, used three tone-
paired 2 s, 0.7 mA foot shocks, and found that Tat(+) mice froze significantly more than Tat(-) 
mice when exposed to the conditioned tone in a new context and took a longer time to extinguish 
the initial tone-paired freezing behavior. Comparing these two studies suggests that Tat(+) mice 
better consolidated the fearful experience when exposed to it multiple times (1 time vs. 3 times). 
Lauterborn et al. (2019) also found that spaced training improved learning on semantic and 









lack of differences seen in experiment 3, as the 2x2 arrangement exposed subjects to a total of 
four context-paired shocks, over the course of two days, ensuring better memory consolidation 
even for the impaired Tat(+) transgenic mice. Perhaps contextual versus cued fear conditioning 
deficits may need to be rethought and reanalyzed in studies that use a different number of shock-
presentations for each type of conditioning, as differences between the two methods may be a 
consequence of repeated training in one (cued) and not the other (contextual).  
 Experiments 2 and 3 may have been limited by the focus on solely reducing variability in 
arrangements, rather than also accounting for arrangements yielding a higher average of freezing. 
Additionally, conditioning and testing trials may have been limited by their length. Fitting et al. 
(2013) and Hahn et al. (2016) both administered a foot shock after three minutes in the 
experimental chamber, while our studies administered shocks at 5 and 8 minutes. This extended 
amount of time may have served as additional habituation to the chamber that may have reduced 
the effectiveness of the fear conditioning. Additionally, because our freezing coding is conducted 
in the first five minutes within the chamber, the percentage of freezing may not account for 
heightened freezing around the expected time of shock. Future studies should ensure that 
conditioning and coding occur within the same time frame of subjects’ placement in the 
chamber. Coding errors resulting in the additional habituation phase in experiment 1 also likely 
reduced the effectiveness of the conditioning phase.  
Future directions should utilize one-trial learning, rather than multiple-trial learning, 
when studying contextual memory in Tat transgenic mice. Graves et al. (2003) found that a high 
intensity (1.5 mA) single shock in CFC produced significant differences between sleep-deprived 









into memory with only a single presentation. Thus, a high-intensity shock may still have the 
potential to yield differences between Tat(+) and Tat(-) mice, rather than act as an upper ceiling, 
and have the potential to be extinguished in future studies. Another study (Drew et al., 2010) 
investigated the arrest of hippocampal neurogenesis on single- and multiple-trial CFC, finding 
that only single-trial CFC was impaired, further supporting that multiple-trial learning in CFC 
overcomes neural deficits. In order for one-trial conditioning to be effective, shock intensity 
should be at least within the range of 0.6-0.8 mA, as the results of experiment 2 indicate that 
two-trial learning of this caliber is effective in producing freezing. Time in the conditioning and 
testing chamber should also be limited so that there is a shorter habituation phase and the context 
is strongly associated with the shock experience. Providing differences are found, it will be 
important to account for neurodegenerative changes in the brain that my contribute to the 
proposed deficit. For instance, investigating proteins associated with structural brain morphology 
via Western Blot may be useful in this quantification. Additionally, Tat protein expression can be 
assessed in different brain regions utilizing mass spectrometry.  
 It is well known that HIV-1 crosses the blood-brain barrier (BBB) within macrophages 
and monocytes and affects the structure and function of multiple neural circuits and systems, 
especially the PFC and hippocampus (Fitting et al., 2013; Kim et al., 2008). Quantification of 
proteins in specific brain regions can provide evidence for structural changes caused by HIV. 
MAP2ab may be used to study dendritic degradation, as downregulation of its binding proteins 
signifies loss of dendritic structure (Harada et al., 2002). Repeated studies have shown that HIV 
is an inflammatory disease in various regions of the body, including the brain (Deeks et al., 









further studied using antibodies for GFAP and IBA-1, well-known markers for astrocytes and 
microglia, respectively. HIV cannot infect neurons, but can infect macrophages, microglia, and 
astrocytes (Nath et al., 1999; Yadav et al., 2009; Li et al., 2007). These infected cells release 
viral proteins including cytokines and chemokines that contribute to functional and structural 
deficits in the CNS. Of these viral proteins, Tat is believed to be a major contributor to the 
neurodegenerative effects observed in HAND (Fitting et al., 2014; Kruman et al., 1994; King et 
al., 2006). Future directions should aim to quantify structural proteins to compare the level of 
hippocampal damage between subjects expressing Tat [Tat(+)] and control subjects [Tat(-)]. 
























CHAPTER 7: CONCLUSION 
 In conclusion, the results of the present study indicate that the 2x2 CFC arrangement 
produces the least variability and average closest to 0.5 in fear-indicative freezing behavior in the 
Tat transgenic mouse model. Furthermore, no significant differences or interactions were found 
between genotype [Tat(+), Tat(-)] and sex (female, male), suggesting that multiple-trial 
paradigms in CFC may be insufficient to assess differences in Tat(+) and Tat(-) mice, as repeated 
learning may cause Tat(+) subjects to consolidate and retrieve fear-associated memories. Future 
studies should determine whether one-trial paradigms are more effective than multiple-trial 
paradigms in assessing differences in Tat transgenic mice, and whether there is a difference in 
results between contextual and cued fear conditioning when controlled for the number of 
learning trials. Based on these results, further experiments are required to assess the neurological 
damage associated with predicted deficits through the quantification of structural proteins, 
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Figure 1. Experiment 1 CFC behavioral data 
 
 
Figure 1. Figure 1 details the results from the CFC pilot study in experiment 1. Data is 
organized, from left to right, by Tat(-) and Tat(+) male transgenic mice. There was no significant 
difference between the percentage freezing of Tat(+) and Tat(-) mice using a 2x1 2 s, 0.4 mA 
















Figure 2. Experiment 2 shock titration behavioral data 
 
 
Figure 2. Figure 2 details results from the shock titration in experiment 2. Data is organized, 
from left to right, as arrangements of 4x1, 2x2, 2x1 (.6), 2x1 (.8) of Tat transgenic mice (not 
administered DOX). The 4x1 arrangement produced the least average of freezing with the 
highest variability. The 2x2 arrangement had a freezing average closest to 0.5 and had the least 
variability out of all arrangements. The 2x1 0.6 mA and 2x1 0.8 mA arrangements produced the 















Figure 3. Experiment 3 2x2 arrangement behavioral data 
 
 
Figure 3. Figure 3 details results from the 2x2 arrangement in experiment 3. Data is organized, 
from left to right, as male Tat(-), female Tat(-), male Tat(+), and female Tat(+) transgenic mice. 
Although female Tat(+) mice froze the least, followed by male Tat(-) mice, there were no 
significant differences or interactions between sex (female, male) or genotype [Tat(-), Tat(+)]. 
 
